Related Experiment Video
Updated: Jul 19, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunction
Ravi K Ramana1, Dominique Joyal, Dinesh Arab
1Loyola University Mediccal Center, Maywood, Illinois 60153, USA.
Insights
Rotational atherectomy (RA) is safe and effective for severe left ventricular (LV) dysfunction patients. This procedure successfully opened lesions without short-term adverse cardiac events, showing feasibility in this high-risk group.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Rotational atherectomy (RA) uses a rotating diamond-crystal burr to treat complex coronary artery lesions.
- RA can generate debris, potentially causing myocardial stunning and worsening left ventricular (LV) dysfunction.
- Manufacturer guidelines advise against RA in patients with severe LV dysfunction.
Purpose of the Study:
- To assess the safety and efficacy of rotational atherectomy (RA) in patients with severe left ventricular (LV) dysfunction (LVEF < 30%).
Main Methods:
- Retrospective review of 23 patients with LVEF < 30% who underwent RA over a 4-year period.
- Analysis of patient risk factors, procedural success, and in-hospital outcomes.
- Evaluation of major adverse cardiac events at 30 days post-procedure.
Main Results:
- RA was 100% successful in lesion treatment with no in-hospital procedure-related mortality.
- Three patients experienced periprocedural myocardial infarctions; one patient died from unrelated malignancy.
- No major adverse cardiac events were observed within 30 days.
Conclusions:
- Rotational atherectomy (RA) did not adversely affect short-term outcomes in patients with severe LV dysfunction.
- RA is a safe and feasible option for selected patients with severe LV dysfunction when performed by experienced operators.
Objective:
To evaluate the safety and efficacy of rotational atherectomy (RA) in patients with severe left ventricular (LV) dysfunction.
Background:
RA, using a rotating diamond-crystal burr, is most commonly used to open lesions with severe calcification or diffuse disease that may prove difficult to cross or dilate. However, RA generates microparticular debris that may attenuate the coronary microcirculation, inducing transient myocardial stunning and LV dysfunction. In fact, the manufacturer does not support RA use in patients with severe LV dysfunction.
Methods:
We retrospectively identified patients with a LV ejection fraction < 30% who underwent RA in our institution over a 4-year period. The medical records were reviewed and risk factors for cardiac disease were recorded. The procedural reports and subsequent hospitalization records were reviewed to identify predetermined positive and negative outcomes.
Results:
Twenty-three patients (17 males) who underwent RA with severe LV dysfunction (mean LVEF 21.3%) were identified. The majority of these patients had multivessel coronary artery disease, hypertension, hyperlipidemia and/or tobacco use. Also, a substantial subset had diabetes, renal insufficiency and or in-stent restenosis. RA was 100% successful in opening the lesions without any in-hospital procedure-related mortality. Three patients experienced periprocedural myocardial infarctions. One patient died from malignancy during hospitalization. There were no major adverse cardiac events at 30 days.
Conclusion:
The transient effect of RA on ventricular function did not adversely affect short-term outcomes in our study population. These results suggest that RA, when performed by experienced operators, is safe and feasible in patients with severe LV dysfunction.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Aortic Regurgitation III: Medical Management
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy V: Interprofessional Care